Key Metrics
Journal Specifications
Indexed in the following public directories
Scopus
SJR
- PublisherTAYLOR & FRANCIS LTD
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1989
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 32% |
4-6 | 49% |
7-9 | 15% |
>9 | 4% |
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Leukemia and Lymphoma been publishing? 
The Leukemia and Lymphoma has been publishing since 1989 till date.
How frequently is the Leukemia and Lymphoma published? 
Leukemia and Lymphoma is published Monthly.
Who is the publisher of Leukemia and Lymphoma? 
The publisher of Leukemia and Lymphoma is TAYLOR & FRANCIS LTD.
How can I view the journal metrics of Leukemia and Lymphoma on editage? 
For the Leukemia and Lymphoma metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Leukemia and Lymphoma? 
The eISSN number is 1029-2403 and pISSN number is 1042-8194 for Leukemia and Lymphoma.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.